Judith Soberman

CMO at Paradox Pharmaceuticals

Judith Soberman, Chief Medical Officer, is a Professor of Cardiovascular Disease at the University of Tennessee Health Science Center and the Memphis Veterans Administration Medical Center with 35 years of clinical and research experience in cardiac arrhythmia, heart failure, and device implantation. She has also been the lead cardiologist on multiple pharmacological clinical trials.

Dr. Soberman is a Certified Cardiac Device Specialist and a Fellow in both the Heart Rhythm Society and the American College of Cardiology and a Diplomate of the American Board of Internal Medicine (Cardiovascular Disease). She has been a funded researcher in preventative cardiology studies including NIDDK-sponsored trials of diabetes management and the Women’s Health Initiative. She has been awarded independent funding for her work in antitumor drug cardiotoxicity/cardioprotection.

Dr. Soberman earned an Sc.B. in Molecular Biology from Brown University and MD from The University of Pittsburgh. She completed her residency training in Internal Medicine at the Albert Einstein College of Medicine (NY), fellowship training in Cardiovascular Pharmacology at the Belfer Institute for Advanced Biomedical Research (NY), and fellowship training in Cardiovascular Disease and Pacemaker/Arrhythmia at the Montefiore Medical Center of the Albert Einstein College of Medicine. Dr. Soberman also holds a Master’s degree in Hospital Administration from the University of Memphis, where she holds an adjunct faculty appointment in Biomedical Engineering.

Timeline

  • CMO

    Current role

View in org chart